This trend has the potential to increase further as the use of canonical ICIs (anti-CTLA-4 and anti-PD-1/PD-L1), alone or in combination, is increasing exponentially and nearly 50% of patients treated will experience some form of irAEs (278)
Lowered inflammation , a key driver of arterial stiffening
We provide hormone evaluations and treatments to restore balance and reduce visceral fat
Works cited GLP-1 and Appetite Control: How it Works and Why it's Effective - Westlake Dermatology, accessed April 22, 2025, Role of GLP-1 Receptor Agonists for Weight Loss - YouTube, accessed April 22, 2025, Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists - PubMed Central, accessed April 22, 2025, Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks, accessed April 22, 2025, How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss
Its applications are still being defined, but early results suggest value as part of a personalized longevity plan
Water 13(2):209 Chen W-H et al (2023) Co-pyrolysis of lignocellulosic biomass with other carbonaceous materials: a review on advance technologies, synergistic effect, and future prospectus